Triomics (Series B)
Funding Details
Awarder
Inbox
Date Award
May 28, 2026
Vertical
Oncology AI
Funding Amount
$22,000,000
Company Info
Founders
Sarim Khan
Market
Healthcare
Location
New York, NY, USA
Coinvestors
Lightspeed Venture Partners, Nexus Venture Partners, Oncology Ventures, Precision Health Informatics, Y Combinator
Company Description

Triomics is an oncology AI company building the infrastructure that turns complex, longitudinal cancer records into structured, explainable intelligence. The company's platform supports patient trial matching, pre-visit chart prep, and oncology data abstraction, helping care teams, research teams, and health systems act faster on the information already in the chart.

Links